0
     

Report Added
Report already added
Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic) - Global Forecast to 2027

Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic) - Global Forecast to 2027

The global bronchoscopy market is projected to reach USD 3.7 Billion by 2027 from USD 2.5 Billion in 2022, at a CAGR of 7.9% during the forecasted period (2022 to 2027). Market growth is largely driven by the rising prevalence of respiratory diseases, the growing demand for minimally invasive surgeries, growing hospital investments in bronchoscopy facilities, and technological advancements in bronchoscopes. On the other hand, the dearth of trained physicians and pulmonologists is a major challenge to the growth of this market.

“The Bronchoscopes are accounted to hold the largest share of the bronchoscopy market, by product in 2021.”

Based on product, the bronchoscopy equipment market is segmented into bronchoscopes, imaging systems, accessories, and other bronchoscopy equipment. The bronchoscopes segment accounted for the largest share of the bronchoscopy equipment market in 2021. The large share of this segment can be attributed to the high cost of bronchoscopes compared to imaging systems and accessories, the increasing prevalence of lung cancer, and technological advancements

“The Bronchial treatment are accounted to hold the largest share of the bronchoscopy market, by application in 2021.”

Based on application, the bronchoscopy equipment market is segmented into bronchial treatment and bronchial diagnosis. In 2021, the bronchial treatment segment accounted for the largest share of the market. The large share of this segment can be attributed to the rising prevalence of target diseases.

“North America commanded the largest share of the bronchoscopy in 2021.”

Based on region, the bronchoscopy equipment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America has the largest share of the bronchoscopy equipment market. The large share of the North American market can be attributed to the increasing incidence and prevalence of chronic respiratory diseases, favorable reimbursement scenario in the US, the rising incidence of lung cancer in Canada, rapid increase in healthcare expenditure, easy accessibility to advanced technologies, and the strong presence of market players in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
• By Region: North America (33%), Europe (24%), AsiaPacific (27%), and Rest of the World (16%)

Some of the major players operating in this market Olympus Corporation (Japan), KARL STORZ (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), and FUJIFILM Holdings Corporation (Japan),

List of Companies Profiled in the Report
•Olympus Corporation (Japan)
•KARL STORZ (Germany)
•Ambu A/S (Denmark)
•Boston Scientific Corporation (US)
•Ethicon (US)
•FUJIFILM Holdings Corporation (Japan)
•Medtronic (Ireland)
•HOYA Corporation (Japan)
•Richard Wolf GmbH (Germany)
•Cook Medical (US)
•Broncus Medical Inc. (China)
•CONMED (US)
•Roper Technologies (US)
•Teleflex Incorporated (US)
•Laborie Medical Technologies Corp. (Canada)
•EFER Endoscopy (France)
•EMOS Technology GmbH (Germany)
•VBM Medizintechnik GmbH (Germany)
•Hunan Vathin Medical Instrument Co. Ltd. (China)
•Machida Endoscope Co. Ltd. (China)

Research Coverage
This report studies the bronchoscopy equipment market based on product, application, usability, patient and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total bronchoscopy equipment market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

•Market Penetration: Comprehensive information on bronchoscopy equipment offered by the top 20 players in the bronchoscopy equipment market. The report analyzes the bronchoscopy market product, application, usability, patient and region.
•Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
•Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bronchoscopy equipment market
•Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the bronchoscopy market
Table of Contents

1INTRODUCTION39
1.1STUDY OBJECTIVES39
1.2MARKET DEFINITION39
1.2.1INCLUSIONS AND EXCLUSIONS40
1.3MARKET SCOPE40
1.3.1MARKET SEGMENTATION40
1.3.2GEOGRAPHIC SCOPE41
1.3.3YEARS CONSIDERED41
1.4CURRENCY42
1.5LIMITATIONS42
1.6STAKEHOLDERS42
1.7SUMMARY OF CHANGES43
2RESEARCH METHODOLOGY44
2.1RESEARCH DATA44
FIGURE 1RESEARCH DESIGN44
2.1.1SECONDARY DATA45
2.1.1.1Key data from secondary sources46
2.1.2PRIMARY DATA46
FIGURE 2PRIMARY SOURCES46
2.1.2.1Key data from primary sources47
2.1.2.2Key industry insights48
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS48
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION49
2.2MARKET SIZE ESTIMATION49
FIGURE 5REVENUE SHARE ANALYSIS ILLUSTRATION50
FIGURE 6MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF BRONCHOSCOPY EQUIPMENT MARKET50
FIGURE 7CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS51
FIGURE 8TOP-DOWN APPROACH52
2.3MARKET BREAKDOWN AND DATA TRIANGULATION53
FIGURE 9DATA TRIANGULATION METHODOLOGY53
2.4MARKET SHARE ANALYSIS54
2.5STUDY ASSUMPTIONS54
2.6RISK ASSESSMENT/FACTOR ANALYSIS54
TABLE 1RISK ANALYSIS54
3EXECUTIVE SUMMARY55
FIGURE 10BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)55
FIGURE 11BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)56
FIGURE 12BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2022 VS. 2027 (USD MILLION)56
FIGURE 13BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2022 VS. 2027 (USD MILLION)57
FIGURE 14BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)57
FIGURE 15BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)58
4PREMIUM INSIGHTS59
4.1BRONCHOSCOPY EQUIPMENT MARKET OVERVIEW59
FIGURE 16RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET59
4.2ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT AND COUNTRY (2021)60
FIGURE 17BRONCHOSCOPES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 202160
4.3GEOGRAPHICAL SNAPSHOT OF BRONCHOSCOPY EQUIPMENT MARKET61
FIGURE 18CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD61
5MARKET OVERVIEW62
5.1INTRODUCTION62
5.2MARKET DYNAMICS62
FIGURE 19BRONCHOSCOPY EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES62
5.2.1DRIVERS63
5.2.1.1Rising prevalence of respiratory diseases63
5.2.1.2Increasing cases of lung cancer63
TABLE 2LUNG CANCER INCIDENCE, BY COUNTRY, 202063
5.2.1.3Growing demand for minimally invasive surgeries64
5.2.1.4Growing hospital investments in bronchoscopy facilities64
5.2.1.5Technological advancements65
5.2.2RESTRAINTS65
5.2.2.1High overhead cost of bronchoscopy procedures65
TABLE 3AGE, NUMBER OF REPAIRS, AVERAGE REPAIR COST PER BREAKAGE, RANGE OF REPAIR COST, AND TOTAL REPAIR COST BY SCOPE OVER A 3-YEAR PERIOD (MAY 2018–APRIL 2021)66
5.2.2.2Risks associated with bronchoscopy66
5.2.3OPPORTUNITIES67
5.2.3.1Growing healthcare market in emerging economies67
FIGURE 20GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRICS COUNTRIES, 2012–201968
5.2.4CHALLENGES68
5.2.4.1Dearth of trained physicians and pulmonologists68
5.2.5BURNING ISSUES68
5.2.5.1Product recalls68
TABLE 4LIST OF PRODUCT RECALLS68
5.3RANGES/SCENARIOS69
FIGURE 21REALISTIC SCENARIO69
FIGURE 22PESSIMISTIC SCENARIO70
FIGURE 23OPTIMISTIC SCENARIO70
5.4REGULATORY ANALYSIS71
TABLE 5LIST OF REGULATORY AUTHORITIES71
5.4.1NORTH AMERICA71
5.4.1.1US71
TABLE 6US: FDA MEDICAL DEVICE CLASSIFICATION72
TABLE 7US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS72
5.4.1.2Canada73
TABLE 8CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS73
5.4.2EUROPE73
5.4.3ASIA PACIFIC73
5.4.3.1Japan73
TABLE 9JAPAN: CLASSIFICATION OF MEDICAL DEVICES74
5.4.3.2China74
TABLE 10CHINA: CLASSIFICATION OF MEDICAL DEVICES74
5.4.3.3India76
5.5PORTER’S FIVE FORCES ANALYSIS77
5.5.1THREAT OF NEW ENTRANTS77
5.5.1.1High capital requirement77
5.5.1.2High preference for products from well-established brands77
5.5.2THREAT OF SUBSTITUTES77
5.5.2.1Substitute therapies for bronchoscopy77
5.5.3BARGAINING POWER OF SUPPLIERS78
5.5.3.1Presence of several raw material suppliers78
5.5.3.2Supplier switching cost78
5.5.4BARGAINING POWER OF BUYERS78
5.5.4.1Few companies offer premium products at global level78
5.5.5INTENSITY OF COMPETITIVE RIVALRY78
5.5.5.1Increasing demand for high-quality and innovative products78
5.5.5.2Lucrative growth potential in emerging markets78
5.6SUPPLY CHAIN ANALYSIS79
FIGURE 24DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES79
5.7VALUE CHAIN ANALYSIS80
FIGURE 25VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES80
5.8ECOSYSTEM ANALYSIS81
FIGURE 26ECOSYSTEM ANALYSIS OF BRONCHOSCOPY EQUIPMENT MARKET81
5.8.1ROLE IN ECOSYSTEM81
FIGURE 27KEY PLAYERS IN BRONCHOSCOPY EQUIPMENT MARKET ECOSYSTEM82
5.9TECHNOLOGY ANALYSIS82
5.10KEY CONFERENCES AND EVENTS IN 2022–202383
TABLE 11BRONCHOSCOPY EQUIPMENT MARKET: DETAILED LIST OF CONFERENCES AND EVENTS83
5.11PATENT ANALYSIS86
5.11.1PATENT TRENDS FOR BRONCHOSCOPY EQUIPMENT86
FIGURE 28PATENT TRENDS FOR BRONCHOSCOPES, JANUARY 2011–AUGUST 202286
5.11.2JURISDICTION AND TOP APPLICANT ANALYSIS86
FIGURE 29TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BRONCHOSCOPES PATENTS, JANUARY 2011— AUGUST 202287
5.12TRADE ANALYSIS87
TABLE 12IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017–2021 (USD MILLION)87
TABLE 13EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017–2021 (USD MILLION)88
5.13PRICING ANALYSIS88
TABLE 14AVERAGE SELLING PRICE OF BRONCHOSCOPES88
TABLE 15COST OF BRONCHOSCOPY EQUIPMENT88
5.14KEY STAKEHOLDERS AND BUYING CRITERIA91
5.14.1KEY STAKEHOLDERS IN BUYING PROCESS91
FIGURE 30INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS91
TABLE 16INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS91
5.14.2BUYING CRITERIA91
FIGURE 31KEY BUYING CRITERIA FOR END USERS OF BRONCHOSCOPY EQUIPMENT91
TABLE 17KEY BUYING CRITERIA FOR END USERS OF BRONCHOSCOPY EQUIPMENT92
5.15TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES92
5.15.1REVENUE POCKETS FOR BRONCHOSCOPY EQUIPMENT MANUFACTURERS92
FIGURE 32REVENUE SHIFT FOR BRONCHOSCOPY EQUIPMENT92
6BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT93
6.1INTRODUCTION94
TABLE 18BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)94
6.2BRONCHOSCOPES94
TABLE 19FLEXIBLE VS. RIGID BRONCHOSCOPY95
TABLE 20INDICATIONS FOR FLEXIBLE AND RIGID BRONCHOSCOPY95
TABLE 21BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)96
TABLE 22BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)96
6.2.1BY TYPE96
6.2.1.1Flexible bronchoscopes96
6.2.1.1.1Most widely adopted bronchoscopes96
TABLE 23ADVANTAGES AND DISADVANTAGES OF FLEXIBLE BRONCHOSCOPES97
TABLE 24FLEXIBLE BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)97
6.2.1.2Rigid bronchoscopes97
6.2.1.2.1Complications associated with rigid bronchoscopy to limit adoption97
TABLE 25ADVANTAGES AND DISADVANTAGES OF RIGID BRONCHOSCOPES98
TABLE 26RIGID BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)98
6.2.1.3EBUS bronchoscopes98
6.2.1.3.1EBUS bronchoscopes to register steady growth during forecast period98
TABLE 27EBUS BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)99
6.2.2BY WORKING CHANNEL DIAMETER99
TABLE 28BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)99
6.2.2.12.8 mm99
6.2.2.1.12.8 mm segment to account for largest market share99
TABLE 292.8 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)100
6.2.2.22.2 mm100
6.2.2.2.12.2 mm bronchoscopes mainly used in pediatric patients100
TABLE 302.2 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)100
6.2.2.33.0 mm101
6.2.2.3.1Patient discomfort associated with 3.0 mm diameters limits market growth101
TABLE 313.0 MM-DIAMETER BRONCHOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)101
6.2.2.4Other working channel diameters101
TABLE 32BRONCHOSCOPES MARKET FOR OTHER WORKING CHANNEL DIAMETERS, BY REGION, 2020–2027 (USD MILLION)102
6.3IMAGING SYSTEMS102
TABLE 33BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)102
TABLE 34BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)103
6.3.1VIDEO PROCESSORS103
6.3.1.1Video processors to register highest growth during forecast period103
TABLE 35VIDEO PROCESSORS MARKET, BY REGION, 2020–2027 (USD MILLION)103
6.3.2LIGHT SOURCES104
6.3.2.1Light sources essential components of bronchoscopy visualization systems104
TABLE 36LIGHT SOURCES MARKET, BY REGION, 2020–2027 (USD MILLION)104
6.3.3CAMERA HEADS104
6.3.3.1Technological advancements support market growth104
6.3.3.2Single-chip cameras104
6.3.3.33-chip cameras104
6.3.3.4HD cameras104
6.3.3.53D cameras105
6.3.3.64K camera heads105
TABLE 37CAMERA HEADS MARKET, BY REGION, 2020–2027 (USD MILLION)105
6.3.4WIRELESS DISPLAYS AND MONITORS105
6.3.4.1Essential in diagnostic and therapeutic procedures105
TABLE 38WIRELESS DISPLAYS AND MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)106
6.3.5OTHER COMPONENTS106
TABLE 39OTHER COMPONENTS MARKET, BY REGION, 2020–2027 (USD MILLION)106
6.4ACCESSORIES107
TABLE 40BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)107
TABLE 41BRONCHOSCOPY ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION)107
6.4.1CYTOLOGY BRUSHES108
6.4.1.1Used to collect cell samples from bronchus108
TABLE 42CYTOLOGY BRUSHES MARKET, BY REGION, 2020–2027 (USD MILLION)108
6.4.2TRANSBRONCHIAL ASPIRATION NEEDLES108
6.4.2.1Transbronchial aspiration needles projected to witness highest growth during forecast period108
TABLE 43TRANSBRONCHIAL ASPIRATION NEEDLES MARKET, BY REGION, 2020–2027 (USD MILLION)108
6.4.3BIOPSY FORCEPS109
6.4.3.1Biopsy forceps aid in diagnosing malignant and nonmalignant disorders109
TABLE 44BIOPSY FORCEPS MARKET, BY REGION, 2020–2027 (USD MILLION)109
6.4.4BIOPSY VALVES109
6.4.4.1Biopsy valves designed for one-time use109
TABLE 45BIOPSY VALVES MARKET, BY REGION, 2020–2027 (USD MILLION)110
6.4.5CLEANING BRUSHES110
6.4.5.1Stringent regulations for cleaning bronchoscopes to drive market110
TABLE 46CLEANING BRUSHES MARKET, BY REGION, 2020–2027 (USD MILLION)110
6.4.6MOUTHPIECES111
6.4.6.1Growing number of bronchoscopy procedures performed to support adoption of mouthpieces111
TABLE 47MOUTHPIECES MARKET, BY REGION, 2020–2027 (USD MILLION)111
6.4.7OTHER ACCESSORIES111
TABLE 48OTHER ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION)112
6.5OTHER BRONCHOSCOPY EQUIPMENT112
TABLE 49OTHER BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION)113
7BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION114
7.1INTRODUCTION115
TABLE 50DIAGNOSTIC AND THERAPEUTIC APPLICATIONS OF BRONCHOSCOPY115
TABLE 51BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)115
7.2BRONCHIAL TREATMENT116
7.2.1LARGEST AND FASTEST-GROWING MARKET SEGMENT116
TABLE 52BRONCHOSCOPY EQUIPMENT MARKET FOR BRONCHIAL TREATMENT, BY REGION, 2020–2027 (USD MILLION)116
7.3BRONCHIAL DIAGNOSIS116
7.3.1INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE MARKET116
TABLE 53NUMBER OF DIAGNOSTIC BRONCHOSCOPY PROCEDURES WITH OR WITHOUT BIOPSY, BY COUNTRY, 2014–2018117
TABLE 54BRONCHOSCOPY EQUIPMENT MARKET FOR BRONCHIAL DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION)117
8BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY118
8.1INTRODUCTION119
TABLE 55BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)119
8.2REUSABLE EQUIPMENT119
8.2.1REUSABLE EQUIPMENT OFFERS HIGH IMAGE QUALITY119
TABLE 56REUSABLE BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION)120
8.3DISPOSABLE EQUIPMENT120
8.3.1DISPOSABLE EQUIPMENT SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD120
TABLE 57DISPOSABLE BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION)121
9BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT122
9.1INTRODUCTION123
TABLE 58BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)123
9.2ADULT PATIENTS123
9.2.1HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES IN ADULT PATIENTS MAJOR FACTOR DRIVING MARKET GROWTH123
TABLE 59BRONCHOSCOPY EQUIPMENT MARKET FOR ADULT PATIENTS, BY REGION, 2020–2027 (USD MILLION)124
9.3PEDIATRIC PATIENTS124
9.3.1IMPROVING HEALTHCARE INFRASTRUCTURE IN EMERGING COUNTRIES TO SUPPORT MARKET GROWTH124
TABLE 60RIGID BRONCHOSCOPE SIZES FOR CHILDREN124
TABLE 61BRONCHOSCOPY EQUIPMENT MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2020–2027 (USD MILLION)125
10BRONCHOSCOPY EQUIPMENT MARKET, BY END USER126
10.1INTRODUCTION127
TABLE 62MEDICARE NATIONAL AVERAGE COVERAGE FOR BRONCHOSCOPY PROCEDURES AT HOSPITALS, AMBULATORY SURGERY CENTERS, AND IN-OFFICE FACILITIES, 2019127
TABLE 63BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)128
10.2HOSPITALS128
10.2.1LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR BRONCHOSCOPY EQUIPMENT128
TABLE 64BRONCHOSCOPY EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)129
10.3AMBULATORY SURGERY CENTERS/CLINICS130
10.3.1COST-EFFECTIVENESS OF ASCS TO DRIVE MARKET130
TABLE 65US: NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS, 2013–2017130
TABLE 66US: AMBULATORY SURGERY CENTER PROCEDURES, 2015–2021 (MILLION)130
TABLE 67US: AMBULATORY SURGERY CENTERS, BY STATE, 2019131
TABLE 68BRONCHOSCOPY EQUIPMENT MARKET FOR AMBULATORY SURGERY CENTERS/CLINICS, BY REGION, 2020–2027 (USD MILLION)131
11BRONCHOSCOPY EQUIPMENT MARKET, BY REGION132
11.1INTRODUCTION133
TABLE 69LUNG CANCER CASES, BY REGION, 2020133
TABLE 70DEATHS DUE TO LUNG CANCER, BY REGION, 2020133
TABLE 71FIVE-YEAR PREVALENCE OF LUNG CANCER, BY REGION, 2020134
TABLE 72BRONCHOSCOPY EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION)134
11.2NORTH AMERICA135
FIGURE 33NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET SNAPSHOT135
TABLE 73NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 74NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)136
TABLE 75NORTH AMERICA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)136
TABLE 76NORTH AMERICA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)137
TABLE 77NORTH AMERICA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)137
TABLE 78NORTH AMERICA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)138
TABLE 79NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)138
TABLE 80NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)138
TABLE 81NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)139
TABLE 82NORTH AMERICA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)139
11.2.1US139
11.2.1.1Largest market for bronchoscopy equipment due to high healthcare spending139
TABLE 83US: LUNG CANCER INCIDENCE, 2020 VS. 2040139
TABLE 84US: KEY MACROINDICATORS140
TABLE 85MEDICARE COVERAGE FOR BRONCHOSCOPY PROCEDURES140
TABLE 86US: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)141
TABLE 87US: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)141
TABLE 88US: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)142
TABLE 89US: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)142
TABLE 90US: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)142
TABLE 91US: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)143
TABLE 92US: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)143
TABLE 93US: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)143
TABLE 94US: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)143
11.2.2CANADA144
11.2.2.1Long waiting period for bronchoscopy procedures to restrain market growth144
TABLE 95CANADA: LUNG CANCER INCIDENCE, 2018 VS. 2025144
TABLE 96CANADA: KEY MACROINDICATORS145
TABLE 97CANADA: MEDIAN PATIENT WAITING PERIODS FOR TREATMENT AFTER APPOINTMENT WITH SPECIALISTS FOR BRONCHOSCOPY (2018)145
TABLE 98CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)145
TABLE 99CANADA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 100CANADA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)146
TABLE 101CANADA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 102CANADA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)147
TABLE 103CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)147
TABLE 104CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)147
TABLE 105CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)148
TABLE 106CANADA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)148
11.3EUROPE148
TABLE 107EUROPE: ESTIMATED AGE-STANDARDIZED INCIDENCE RATE OF LUNG CANCER, BY COUNTRY, 2020148
TABLE 108EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)150
TABLE 109EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)150
TABLE 110EUROPE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)151
TABLE 111EUROPE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)151
TABLE 112EUROPE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)151
TABLE 113EUROPE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)152
TABLE 114EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)152
TABLE 115EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)152
TABLE 116EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)153
TABLE 117EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)153
11.3.1GERMANY153
11.3.1.1Germany dominates European bronchoscopy equipment market153
TABLE 118GERMANY: LUNG CANCER INCIDENCE, 2018 VS. 2025153
TABLE 119GERMANY: KEY MACROINDICATORS154
TABLE 120GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)154
TABLE 121GERMANY: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 122GERMANY: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)155
TABLE 123GERMANY: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 124GERMANY: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)156
TABLE 125GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)156
TABLE 126GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)156
TABLE 127GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)157
TABLE 128GERMANY: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)157
11.3.2UK157
11.3.2.1Supportive reimbursement policies to drive market157
TABLE 129UK: KEY MACROINDICATORS158
TABLE 130REIMBURSEMENT FOR BRONCHOSCOPY PROCEDURES IN THE UK158
TABLE 131UK: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)159
TABLE 132UK: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)159
TABLE 133UK: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)159
TABLE 134UK: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 135UK: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 136UK: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)160
TABLE 137UK: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)161
TABLE 138UK: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)161
TABLE 139UK: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)161
11.3.3FRANCE161
11.3.3.1Favorable health insurance system to drive market for bronchoscopy equipment161
TABLE 140FRANCE: LUNG CANCER INCIDENCE, 2020 VS. 2040162
TABLE 141FRANCE: KEY MACROINDICATORS162
TABLE 142FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)162
TABLE 143FRANCE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)163
TABLE 144FRANCE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)163
TABLE 145FRANCE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)163
TABLE 146FRANCE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)164
TABLE 147FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)164
TABLE 148FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)164
TABLE 149FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)165
TABLE 150FRANCE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)165
11.3.4SPAIN165
11.3.4.1Well-organized and efficient healthcare system to offer growth opportunities165
TABLE 151SPAIN: LUNG CANCER INCIDENCE, 2018 VS. 2025166
TABLE 152SPAIN: KEY MACROINDICATORS166
TABLE 153SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)166
TABLE 154SPAIN: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)167
TABLE 155SPAIN: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)167
TABLE 156SPAIN: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)167
TABLE 157SPAIN: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)168
TABLE 158SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)168
TABLE 159SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)168
TABLE 160SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)169
TABLE 161SPAIN: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)169
11.3.5ITALY169
11.3.5.1Growing medical tourism and rising geriatric population key factors driving market169
TABLE 162ITALY: LUNG CANCER INCIDENCE, 2018 VS. 2025170
TABLE 163ITALY: KEY MACROINDICATORS170
TABLE 164ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)170
TABLE 165ITALY: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)171
TABLE 166ITALY: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)171
TABLE 167ITALY: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)171
TABLE 168ITALY: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 169ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)172
TABLE 170ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)172
TABLE 171ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)173
TABLE 172ITALY: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)173
11.3.6REST OF EUROPE173
TABLE 173REST OF EUROPE: LUNG CANCER INCIDENCE, 2020 VS. 2040174
TABLE 174REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP)174
TABLE 175REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)174
TABLE 176REST OF EUROPE: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)175
TABLE 177REST OF EUROPE: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)175
TABLE 178REST OF EUROPE: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)175
TABLE 179REST OF EUROPE: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)176
TABLE 180REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)176
TABLE 181REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)176
TABLE 182REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)177
TABLE 183REST OF EUROPE: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)177
11.4ASIA PACIFIC177
TABLE 184ASIA PACIFIC: ESTIMATED AGE-STANDARDIZED INCIDENCE RATE FOR LUNG CANCER, BY COUNTRY, 2020177
FIGURE 34ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET SNAPSHOT179
TABLE 185ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)180
TABLE 186ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)180
TABLE 187ASIA PACIFIC: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)180
TABLE 188ASIA PACIFIC: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)181
TABLE 189ASIA PACIFIC: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 190ASIA PACIFIC: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 191ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)182
TABLE 192ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)182
TABLE 193ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)182
TABLE 194ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)183
11.4.1CHINA183
11.4.1.1Large patient population to favor market growth183
TABLE 195CHINA: KEY MACROINDICATORS184
TABLE 196CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)184
TABLE 197CHINA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)184
TABLE 198CHINA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)185
TABLE 199CHINA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)185
TABLE 200CHINA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)185
TABLE 201CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)186
TABLE 202CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)186
TABLE 203CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)186
TABLE 204CHINA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)186
11.4.2JAPAN187
11.4.2.1Growing geriatric population to support market growth187
TABLE 205JAPAN: LUNG CANCER INCIDENCE, 2020 VS. 2040187
TABLE 206JAPAN: KEY MACROINDICATORS188
TABLE 207JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)188
TABLE 208JAPAN: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)188
TABLE 209JAPAN: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)189
TABLE 210JAPAN: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)189
TABLE 211JAPAN: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)189
TABLE 212JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)190
TABLE 213JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)190
TABLE 214JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)190
TABLE 215JAPAN: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)190
11.4.3INDIA191
11.4.3.1Healthcare infrastructural development and favorable government initiatives key factors supporting market growth191
TABLE 216INDIA: LUNG CANCER INCIDENCE, 2018 VS. 2025191
TABLE 217INDIA: KEY MACROINDICATORS191
TABLE 218INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)192
TABLE 219INDIA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)192
TABLE 220INDIA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)192
TABLE 221INDIA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)193
TABLE 222INDIA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)193
TABLE 223INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)193
TABLE 224INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)194
TABLE 225INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)194
TABLE 226INDIA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)194
11.4.4AUSTRALIA194
11.4.4.1High prevalence of cancer to drive demand for bronchoscopy194
TABLE 227AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)195
TABLE 228AUSTRALIA: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)195
TABLE 229AUSTRALIA: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)196
TABLE 230AUSTRALIA: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)196
TABLE 231AUSTRALIA: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)196
TABLE 232AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)197
TABLE 233AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)197
TABLE 234AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)197
TABLE 235AUSTRALIA: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)197
11.4.5REST OF ASIA PACIFIC198
TABLE 236REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION)198
TABLE 237REST OF ASIA PACIFIC: BRONCHOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)199
TABLE 238REST OF ASIA PACIFIC: BRONCHOSCOPES MARKET, BY WORKING CHANNEL DIAMETER, 2020–2027 (USD MILLION)199
TABLE 239REST OF ASIA PACIFIC: BRONCHOSCOPY IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)199
TABLE 240REST OF ASIA PACIFIC: BRONCHOSCOPY ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)200
TABLE 241REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)200
TABLE 242REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY USABILITY, 2020–2027 (USD MILLION)200
TABLE 243REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY PATIENT, 2020–2027 (USD MILLION)201
TABLE 244REST OF ASIA PACIFIC: BRONCHOSCOPY EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION)201

Report Title: Bronchoscopy Market by Product Bronchoscopes (Flexible, Rigid, EBUS), Imaging Systems (Video Processors), Accessories (Cytology Brushes), Application (Bronchial Treatment), Usability (Reusable), & End Users (Hospital, ACSs/Clinic) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region